MRC MHU

At the MRC MHU we believe that studying the molecular science underpinning medicine gives us the power to transform healthcare. 🧫🔬🩺 youtu.be/UN19lLruvtI

Really enjoyed doing this short interview about our research and @NaturePortfolio publication on developing models of infant leukaemia. @OxPaediatrics @MRC_MHU @MRC_WIMM @milnetom68 @SiobhanRice12 @wellcometrust @bloodcancer_uk

Congratulations to Adam Wilkinson, who has received the 2025 Janet Rowley Award from the @ISEHSociety for his outstanding contributions to the field of hematopoietic stem cell biology 🎉 Read more: imm.ox.ac.uk/news/wilkinson… @awilkinsongroup | @RDMOxford

For International Women's Day tomorrow, we asked some of our women scientists, including @MiraKassouf & @DrSarahGooding, to reflect on why this day is so important. #IWD2025 #InternationalWomensDay Watch: youtu.be/dEm2DUbxC9o

The sequencing of treatments in #MultipleMyeloma is a highly complex topic. What factors should clinicians consider when making sequencing decisions & how may approaches be personalized in the future? Hear from @DrSarahGooding of @MRC_MHU: 👉 ow.ly/wUmo50V6Y43 👈 #MMSM

To conclude our @rarediseaseday series, we spoke with @el_louka26, a clinician scientist researching Paediatric Myelodysplastic Syndromes & Juvenile Myelomonocytic Leukaemia - very rare childhood cancers with no current treatment options available. Watch: youtu.be/MsfAcM39tMk

For Rare Disease Day this Friday, we spoke with @DrSarahGooding, a clinician scientist in @Chapman_lab_UK at the MRC WIMM researching multiple myeloma, a currently incurable type of bone marrow cancer that desperately requires friendlier therapies. Watch: youtu.be/-H16Wd443EI

🎥 Abdullah Khan (@AbAttacks) of @MRC_WIMM discusses the engineering of physiologically complex human pre-clinical models and their applications for #MultipleMyeloma: 👉 ow.ly/2WF250V2GRN 👈 #MMSM #Myeloma #HemOnc

NEW preprint from @AbAttacks & colleagues:

At the MRC WIMM, we foster a strong culture of innovation. We spoke with some of our current and former Group Leaders who have developed their discoveries into commercial ventures to translate their research into clinics and benefit patients: youtu.be/6vSP3QLfQ4Q

Well done @ling_r for presenting your DPhil project at OCH Day @MRC_WIMM @OxfordCancer @OxPaediatrics

Happy to share this story where we show selection of therapy-resistant clones in patients treated for IDH1-mutant myeloid malignancy months to years before relapse. This has been a great collaboration between researchers from @MRC_WIMM and @MDAndersonNews. 🧵 below.

I am two days late with this, but congratulations to Vassi Sharlandjieva for successfully defending her thesis! And a big thanks to examiners Brian Huntly and @andiroy ! @MRC_WIMM @MRC_MHU

On Radio 4 TODAY - Listen to @AbAttacks from the @MRC_MHU talking about how organoid research could help develop better treatments on the latest episode of Best Medicine 🧫 6:30 pm on Radio 4 or online now! bbc.co.uk/programmes/m00…

❄️ Season's Greetings from the MRC WIMM ❄️ Each year, we hold a decorating contest to fill labs and offices in the Institute with festive cheer ☃️ This year's winner was the HSCB Lab & 2nd place went to the Higgs Lab 🥳 youtu.be/Pkmwg582JAk

Registration and abstract submission is now open for this ⁦⁦@EMBO⁩ Childhood Leukaemia workshop that I am excited to help organise. See you in Kolkata!! meetings.embo.org/event/25-paed-…

Congratulations Alastair for a great talk at ASH @MRC_WIMM @andiroy #chromatin #enhancers #genome_architecture:

With just under 2 weeks left to apply for our DPhil programme, watch some of our students and group leaders break down why the MRC WIMM's collaborative environment is the ideal place for research 🧬 🔬 youtu.be/VZmHEKzvvbA Apply here: imm.ox.ac.uk/study-with-us Deadline for RDM…

Last week, we were delighted to host a visit from @bloodcancer_uk staff and community supporters. It was a fantastic opportunity to connect with some of the people who make our research possible and to show first-hand how their support is driving meaningful progress.

Interested in involving the public in your research? Join our webinar on 26 November and hear from public partners about their involvement in lab-based research and strategy. Register: orlo.uk/mwA8E

Wonderful talk from @larsplus for our @MRC_MHU seminar yesterday. Exciting developments and technologies to apply for Haematology research! Thanks for sharing.